{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:52:20Z","timestamp":1792173140234,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajog.2025.08.088","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:07:45Z","timestamp":1756508865000},"page":"297-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes in pregnancy and major new advances in diabetes care using long-acting and ultralong-acting insulins"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7737-8359","authenticated-orcid":false,"given":"Rosa F.","family":"Drummond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle J.","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Albert","family":"Reece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.08.088_bib2","article-title":"Epidemiology and classification of diabetes in pregnancy","author":"McMicking","year":"2021","journal-title":"maternal medical health and disorders in pregnancy."},{"key":"10.1016\/j.ajog.2025.08.088_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0000000000005640","article-title":"Insulin management for gestational and type 2 diabetes in pregnancy","volume":"144","author":"Valent","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/AOG.0000000000005609","article-title":"Continuous glucose monitoring for management of type 2 diabetes and perinatal outcomes","volume":"144","author":"Padgett","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2025.08.088_bib6","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"issue":"Supplement_1","key":"10.1016\/j.ajog.2025.08.088_bib7","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"Management of diabetes in pregnancy: Standards of Care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2337\/dc07-0278","article-title":"Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes","volume":"30","author":"Guerin","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2015.09.082","article-title":"New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects","volume":"214","author":"Dong","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib10","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.ajog.2007.06.070","article-title":"Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy","volume":"198","author":"Yang","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/bdrc.21090","article-title":"Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes","volume":"105","author":"Ornoy","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.ajog.2025.08.088_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00006250-198609000-00015","article-title":"Glycemic control and spontaneous abortion in insulin-dependent diabetic women","volume":"68","author":"Miodovnik","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00125-013-3108-5","article-title":"Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study","volume":"57","author":"Tennant","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2025.08.088_bib14","series-title":"Diabetes and obesity in women: adolescence, pregnancy, and menopause","author":"Reece","year":"2019"},{"key":"10.1016\/j.ajog.2025.08.088_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-2007-994059","article-title":"Pregnancy outcomes among women with and without diabetic microvascular disease (White's classes B to FR) versus non-diabetic controls","volume":"15","author":"Reece","year":"1998","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2025.08.088_bib16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1067\/mob.2000.107621","article-title":"Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of child health and Human development maternal- Fetal Medicine Units Network","volume":"183","author":"Sibai","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9378(98)70382-5","article-title":"Shoulder dystocia and associated risk factors with macrosomic infants born in California","volume":"179","author":"Nesbitt","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib18","doi-asserted-by":"crossref","first-page":"333.e1","DOI":"10.1016\/j.ajog.2012.06.066","article-title":"The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes","volume":"207","author":"Yanit","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1986.03370050073024","article-title":"A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies","volume":"255","author":"Coustan","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.08.088_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated insulin delivery in women with pregnancy complicated by type 1 diabetes","volume":"389","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib21","first-page":"276","article-title":"The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia","volume":"62","author":"Rybicka","year":"2011","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.ajog.2025.08.088_bib22","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.08.088_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/dc14-0649","article-title":"Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes","volume":"38","author":"Porcellati","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib24","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1210\/jc.2018-00094","article-title":"Parity increases insulin requirements in pregnant women with type 1 diabetes","volume":"103","author":"Skajaa","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib25","article-title":"Insulin detemir versus insulin glargine for type 2 diabetes mellitus","volume":"2011","author":"Swinnen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2025.08.088_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/dom.12106","article-title":"A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review","volume":"15","author":"Frier","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib27","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2337\/dc21-0472","article-title":"Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world EVOLVE study","volume":"44","author":"Mathiesen","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib28","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/dom.12052","article-title":"Insulin degludec: overview of a novel ultra long-acting basal insulin","volume":"15","author":"Gough","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib31","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.numecd.2015.06.005","article-title":"Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: a meta-analysis of seven clinical trials","volume":"25","author":"Russell-Jones","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ajog.2025.08.088_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1615692","article-title":"Efficacy and safety of degludec versus glargine in type 2 diabetes","volume":"377","author":"Marso","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40268-016-0134-z","article-title":"A multinational, randomized, open-label, treat-to-target trial comparing insulin degludec and insulin glargine in insulin-na\u00efve patients with type 2 diabetes mellitus","volume":"16","author":"Pan","year":"2016","journal-title":"Drugs R D"},{"key":"10.1016\/j.ajog.2025.08.088_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/dom.12032","article-title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials","volume":"15","author":"Ratner","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/dom.13149","article-title":"A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes","volume":"20","author":"Siegmund","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/dom.12573","article-title":"Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial","volume":"18","author":"Davies","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40262-014-0165-y","article-title":"A review of the pharmacological properties of insulin degludec and their clinical relevance","volume":"53","author":"Haahr","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2025.08.088_bib38","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2337\/dc14-2090","article-title":"Insulin detemir does not cross the human placenta","volume":"38","author":"Suffecool","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dc09-1045","article-title":"Insulin glargine safety in pregnancy: a transplacental transfer study","volume":"33","author":"Pollex","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.08.088_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2020.100064","article-title":"Use of insulin degludec in pregnancy: two case reports and a literature review","volume":"1","author":"Sprio","year":"2020","journal-title":"Endocr Metab Sci"},{"key":"10.1016\/j.ajog.2025.08.088_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jdi.12721","article-title":"Insulin degludec in the first trimester of pregnancy: report of two cases","volume":"9","author":"Milluzzo","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ajog.2025.08.088_bib45","article-title":"Exposure to degludec during pregnancy: a case report","volume":"11","author":"Roman-Gonzalez","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ajog.2025.08.088_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40618-018-0926-9","article-title":"Exposure to insulin degludec during pregnancy: report of a small series and review of the literature","volume":"42","author":"Bonora","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ajog.2025.08.088_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13300-018-0532-z","article-title":"Successful outcomes with insulin degludec in pregnancy: a case series","volume":"10","author":"Hiranput","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ajog.2025.08.088_bib48","article-title":"Assessment of materno-fetal complications in pregnant women with type 1 diabetes exposed to insulin degludec","volume":"63","author":"Mart\u00ednez-Montoro","year":"2019","journal-title":"Endocrine Abstracts"},{"key":"10.1016\/j.ajog.2025.08.088_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.diabres.2019.05.004","article-title":"Treatment with the long-acting insulin analog degludec during pregnancy in women with type 1 diabetes: an observational study of 22 cases","volume":"152","author":"Keller","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2025.08.088_bib50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00592-021-01845-0","article-title":"Pregnancy outcomes in women with type 1 diabetes using insulin degludec","volume":"59","author":"Ringholm","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajog.2025.08.088_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1267248","article-title":"Hypoglycemia and associated comorbidities among newborns of mothers with diabetes in an academic tertiary care center","volume":"11","author":"Bamehrez","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajog.2025.08.088_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2213-8587(22)00307-2","article-title":"EXPECT study group. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial","volume":"11","author":"Mathiesen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajog.2025.08.088_bib53","article-title":"Insulin degludec cord blood level and neonatal hypoglycaemia in pregnant women with type 1 diabetes in the EXPECT study","volume":"197S","author":"Mathiesen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2025.08.088_bib54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/endrev\/bnad037","article-title":"The basis for weekly insulin therapy: evolving evidence with insulin icodec and insulin efsitora alfa","volume":"45","author":"Rosenstock","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2025.08.088_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.17925\/EE.2023.19.1.4","article-title":"Insulin icodec weekly: a basal insulin analogue for type 2 diabetes","volume":"19","author":"Bajaj","year":"2023","journal-title":"touchREV Endocrinol"},{"key":"10.1016\/j.ajog.2025.08.088_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2303208","article-title":"Weekly icodec versus daily glargine U100 in type 2 diabetes without previous insulin","volume":"389","author":"Rosenstock","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-8587(23)00093-1","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial","volume":"11","author":"Philis-Tsimikas","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajog.2025.08.088_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.2023.11313","article-title":"Once-weekly insulin icodec vs once-daily insulin degludec in adults with insulin-naive type 2 diabetes: the ONWARDS 3 randomized clinical trial","volume":"330","author":"Lingvay","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.08.088_bib60","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(23)00520-2","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial","volume":"401","author":"Mathieu","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.08.088_bib61","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.7326\/M23-1288","article-title":"Once-weekly insulin icodec with dosing guide app versus once-daily basal insulin analogues in insulin-naive type 2 diabetes (ONWARDS 5): a randomized trial","volume":"176","author":"Bajaj","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib62","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(23)02179-7","article-title":"Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial","volume":"402","author":"Russell-Jones","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.08.088_bib63","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1111\/dom.15604","article-title":"Once-weekly insulin efsitora alfa: design and rationale for the QWINT phase 3 clinical development programme","volume":"26","author":"Bergenstal","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.08.088_bib64","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa2403953","article-title":"Insulin efsitora versus degludec in type 2 diabetes without previous insulin treatment","volume":"391","author":"Wysham","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib67","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0140-6736(24)01804-X","article-title":"Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial","volume":"404","author":"Bergenstal","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.08.088_bib68","first-page":"295","article-title":"A story of two miracles: the impact of the discovery of insulin on pregnancy in women with diabetes mellitus","volume":"79","author":"Gabbe","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.08.088_bib69","doi-asserted-by":"crossref","first-page":"F276","DOI":"10.1136\/adc.2003.042739","article-title":"Dr Priscilla white (1900-1989) of Boston and pregnancy diabetes","volume":"89","author":"Dunn","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2025.08.088_bib71","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-0412.2002.810906.x","article-title":"Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]","volume":"81","author":"Mathiesen","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.08.088_bib72","article-title":"Antenatal corticosteroids and their effects on maternal glycemic status: a prospective observational study from an Indian tertiary referral center","volume":"16","author":"Satyaraddi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajog.2025.08.088_bib73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14744","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes - an updated guideline from the Joint British Diabetes Society for Inpatient Care","volume":"39","author":"Dashora","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajog.2025.08.088_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102840","article-title":"Global, regional, and national burden of preterm birth, 1990-2021: a systematic analysis from the global burden of disease study 2021","volume":"76","author":"Liang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2025.08.088_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diaspect.29.2.92","article-title":"Insulin use in pregnancy: an update","volume":"29","author":"Blum","year":"2016","journal-title":"Diabetes Spectr"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825006453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825006453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:00:01Z","timestamp":1780722001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825006453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0002937825006453"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.08.088","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in pregnancy and major new advances in diabetes care using long-acting and ultralong-acting insulins","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.08.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}